OncoMed Pharmaceuticals makes new appointment
This article was originally published in Scrip
Executive Summary
OncoMed Pharmaceuticals, a US clinical-stage company developing antibody therapeutics that target cancer stem cells, has appointed Sunil Patel senior vice-president of corporate development. He joins from BiPar Sciences, where as vice-president of corporate development and marketing he led the sale of the company to Sanofi-Aventis in April (scripnews.com, April 16th, 2009).